3.2 Innovation and research

Innovation and research are critically important in the field of AMR, as there is a strong need for new therapeutics, diagnostics and innovative infection prevention and intervention measures. Understanding how to communicate with these stakeholders is valuable for furthering research and innovation in the area of AMR you are interested in.

Several research and development initiatives address AMR for human health and very few for animal health. In human health, several international initiatives have been launched to stimulate research, including:

• Joint Programming Initiative on Antimicrobial Resistance (JPIAMR)
• Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)
• New Drugs for Bad Bugs (ND4BB)
• Global Antibiotic Research & Development Partnership (GARDP)
• Novo REPAIR Impact Fund.

There are fewer global research and development initiatives in animal health, and they are less likely to have a specific focus on AMR:

• GALVmed
• Livestock Vaccine Innovation Fund.

These initiatives operate with limited budgets and contribute to the response to research and development challenges.

In this section we will take a deeper look at how JPIAMR and GALVmed are supporting and promoting innovation and research in AMR. We will also consider how best to engage with each organisation.